
Dr Alessio Cortellini is a consultant in medical oncology and a clinical scientist with a special interest in immunotherapy of cancer and lung cancer. After leading the immunotherapy program at University of L’Aquila in Italy for more than a year, he moved to London in 2020, where he worked in the early phase clinical trial unit at Imperial College London.
In July 2022, he moved to Rome and he is now working at the Fondazione Policlinico Universitario Campus Bio-Medico in Rome. However, given the fruitful collaboration and the number of high-level research goals achieved during his fellowship at Imperial College, he is keeping his honorary academic post as Honorary Clinical Lecturer with Imperial College London.